Intrapulmonary artery infusion of urokinase for treatment of massive pulmonary embolism: A review of 26 patients with and without contraindications to systemic thrombolytic therapy

Clinical Cardiology

Volumn 22, Issue 10, 1999, Pages 661-664

  McCotter, C J ^a   Chiang, K S ^a   Fearrington, E L ^a,b  

^a EAST CAROLINA UNIVERSITY   (United States)

^b PITT COUNTY MEMORIAL HOSPITAL   (United States)

Author keywords

Intrapulmonary thrombolytic; Pulmonary emboli; Thrombolytic therapy

Indexed keywords

UROKINASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DOSE CALCULATION; DRUG EFFECT; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LUNG EMBOLISM; MALE; MORBIDITY; MORTALITY; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 0032850848     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960221014     Document Type: Article

References (18)

1. Hirsh J, Hoak J: Management of deep vein thrombosis and pulmonary embolism. Circulation 1996;93:2212-2245
2. Dismuke SE, Wagner EH: Pulmonary embolism as a cause of death. The changing mortality in hospitalized patients. J Am Med Assoc 1986;255:2039-2042
3. Colantonio D, Casale R, Lorenzetti G, Pasqualetti P: Fatal pulmonary thromboembolism. A study of 178 cases. Minerva Cardioangiologica 1990;38:23-26
4. Sandler DA, Martin JF: Autopsy proven pulmonary embolism in hospital patients: Are we detecting enough deep vein thrombosis? J Roy Soc Med 1989;82:203-205
5. Gallerani M, Manfredini R, Ricci L, Grandi E, Cappato R, Calo G, Paraschi PL, Fersini C: Sudden death from pulmonary thromboembolism: Chronobiological aspects (review). Eur Heart J 1992;13: 661-665
6. Daisley H: Pulmonary embolism as a cause of death. West Indian Med J 1990;39:86-90
7. Proctor MC, Greenfield LJ: Pulmonary embolism: Diagnosis, incidence and implications. Cardiovasc Surg 1997;5:77-81
8. Tuncer RA, Erkaya S, Sipahi T, Kutlar I: Maternal mortality in a maternity hospital in Turkey. Acta Obslet et Gyncecol Scand 1995; 74:604-606
9. Brazuzzi AC, Knobel E, Cirenza C, Smith MR, Barbas CS, Fernandes CJ Jr, Akamine N: Hemodynamic impact of thrombolytic therapy in acute pulmonary thromboembolism (in Portuguese). Arquivos Brazileiros de Cardiologia 1995;64:515-520
10. Pacouret G, Barnes SJ, Hopkins G, Charbonnier B: Rapid haemodynamic improvement following saruplase in recent massive pulmonary embolism. Thromb Haemost 1998;79:264-267
11. Fava M, Loyola S, Flores P, Huete I: Mechanical fragmentation and pharmacologic thrombolysis in massive pulmonary embolism. J Vase Intervent Radiol 1997;8:261-266
12. Grau E, Fontcuberta J, Pages M, Martinez R, Felez J, Net A, Rutllant M: Massive pulmonary embolism: Short-term effects of thrombolytic treatment. Angiology 1986;37:832-839
13. Goldhaber SZ: Contemporary pulmonary embolism thrombosis (review). Chest 1995;107(1 suppl):45S-51S
14. Konstantinides S, Tiede N, Geibel A, Olschewski M, Just H, Kasper W: Comparison of alteplase versus heparin for resolution of major pulmonary embolism. Am J Cardiol 1998;82:966-970
15. Ouriel K, Welch EL, Shortell CK, Geary K, Fiore WM, Cimino C: Comparison of streptokinase, urokinase, and recombinant tissue plasminogen activator in an in vitro model of venous thrombolysis. J Vasc Surg 1995;22:593-597
16. Kramer WB, Belfort M, Saade GR, Surani S, Moise KJ Jr: Successful urokinase treatment of massive pulmonary embolism in pregnancy. Angiology 1986:37:832-839
17. Sanchez-Burson J, Corzo JE, Marenco JL, Rejon-Gieb E: Thrombolytic therapy in pulmonary embolism of Beheet's disease. Acta Haematol 1996;93:181-183
18. Kasper W, Konstantinides S, Geibel A, Olschewski M, Henrich F, Grosser KD, Rauber K, Iversen S, Redecker M, Kienast J: Management of strategies and determinants of outcome in acute major pulmonary embolism: Results of a multicenter registry. J Am Coll Cardiol 1997;30:1165-1171